2,762
Views
3
CrossRef citations to date
0
Altmetric
Articles

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection

ORCID Icon, , , , , , , & show all
Pages 2629-2633 | Received 22 Feb 2022, Accepted 27 Mar 2022, Published online: 11 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opinion on Drug Safety 22:1, pages 43-58.
Read now

Articles from other publishers (2)

Angelo Ruggiero, Luca Potestio, Elisa Camela, Gabriella Fabbrocini & Matteo Megna. (2022) Reply to “Routine rescreening for latent tuberculosis has low utility in patients with chronic immune-mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study”. Journal of the American Academy of Dermatology 87:6, pages e239-e240.
Crossref
Iulia-Alexandra Paliu, Simona-Laura Ianosi, Adina Turcu-Stiolica, Catalina-Gabriela Pisoschi, Luminita-Georgeta Predoi & Andrei-Adrian Tica. (2022) Vitamin D May Be Connected with Health-Related Quality of Life in Psoriasis Patients Treated with Biologics. Journal of Personalized Medicine 12:11, pages 1857.
Crossref